The mammogram is an important breast cancer screening and diagnostic tool for women. This highly effective, non-invasive, and inexpensive procedure detects breast cancer and saves lives. The American Cancer Society recommends women start breast cancer screening at age 45. However, research has found mammograms are most beneficial for women age 50 and older. Regular mammograms reduce the risk of dying from breast cancer by 14% among 50- to 60-year-olds and 33% among 60- to 69-year-olds.
There are numerous misconceptions, or myths, floating around about who is or isn't likely to get breast cancer. And, we believe it is important to address a few of these common breast cancer myths.
Clearing up any misconceptions that you may have about breast cancer can bring awareness and understanding to this common disease. So allow our breast cancer specialists dispel some of these myths and misconceptions.
Since 1985, the month of October is breast cancer has been celebrated as Breast Cancer Awareness month. This annual international campaign organized by major breast health charities aims to raise awareness of the disease and the value of screening and early detection and to raise money for research into breast cancer prevention, diagnosis, treatment, and cures.
Across the U.S., the number of events seems to grow with every passing October. The Portland-Vancouver metroplex is no exception.
If you’ve had a mammogram and were told you have dense breast tissue, you may be wondering what that means. While having dense breasts is normal and common, many women are left feeling uncertain regarding whether there is anything they should do differently or how it affects the risk of getting breast cancer.
Breasts contain glandular, connective, and fat tissue. Breast density is a term that describes the relative amount of these different types of breast tissue as seen on a mammogram. Dense breasts have more glandular tissue and fibrous connective tissue and than fatty breast tissue. Dense breasts can be inherited.
Inflammatory breast cancer is a rare but aggressive form of breast cancer. Accounting for less than 5% of all breast cancer diagnoses, the cancer forms in the cells that line the breasts’ milk ducts, but quickly spreads to nearby lymph nodes and sometimes other tissues in the body. The cancer is called “inflammatory” because the cancer cells usually block the lymph vessels in the breast. This causes fluid to build up, which leads to inflammation that is usually red and tender.
Compared to slower-growing forms of breast cancer, inflammatory breast cancer progresses and spreads through the body quickly – sometimes in a matter of weeks.
It’s common for cancer patients and their families to feel helpless, as if their futures and those of their loved ones are entirely dependent on physicians and medications. Genetic testing is one way for cancer patients and their relatives to regain a sense of control over the disease, and make a valuable contribution toward improving its detection, treatment and prevention.
One of the most effective ways for cancer researchers to learn why a type of cancer occurs (an important step in discovering treatments) is to study the genes of patients and those who share their DNA profile.
As a breast cancer patient or breast cancer survivor, it’s important to stay active – even if you don’t feel up to it.
In a recent study by Kerry Courneya, PhD, found that women with breast cancer that participated in a resistance training program during chemotherapy required less dosage and fewer delays in their chemotherapy treatments. Of course, if you’re undergoing breast cancer treatment, you should first discuss exercise with your doctor. For most breast cancer patients, rigorous activity isn’t recommended, but regular moderate exercise, such as walking or strength training with light weights, can help you to feel better, and as strange as it may sound, you might even feel less tired than before you exercised.
While one in eight women will develop breast cancer during her lifetime, dramatic advances have been made in the diagnosis, treatment and prevention of the disease. We can now test each patient’s tumor for molecular and genetic changes. This allows us to understand the exact biologic process taking place and better choose the medications and therapies that are targeted directly for that cancer. Some call this personalized medicine, some call it precision medicine and some call it targeted therapy. Regardless of the name, the result is breast cancer has an excellent survival rate when caught early.
